C07K 14/125
Newcastle disease virus
C07K14/125 (Newcastle disease virus) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C07K- Granted patents
- 2
- Published applications
- 3
- Assignees
- 2
- Inventors
- 5
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Recombinant vaccine against Marek's disease and Newcastle disease25 Mar 2025US 12,258,372 B2The United States of America as represented by the Secretary of Agriculture
- Recombinant vaccine against Marek's disease and Newcastle disease12 Apr 2022US 11,299,517 B2The United States of America as represented by the Secretary of Agriculture
- An immune checkpoint-modulating vsv-ndv hybrid virus for oncolytic virus immunotherapy of cancer30 Nov 2023US 2023/0381256 A1Klinikum Rechts Der Isar Der Technischen UniversitäT MüNchen
- Recombinant vaccine against marek's disease and newcastle disease16 Jun 2022US 2022/0185848 A1The United States of America as represented by the Secretary of Agriculture
- Recombinant vaccine against marek's disease and newcastle disease21 Oct 2021US 2021/0324016 A1The United States of America as represented by the Secretary of Agriculture
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.